Title : Pharmacoeconomics of liposomal anthracycline therapy.

Pub. Date : 2004 Dec

PMID : 15717744






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pharmacoeconomic analyses of data from clinical trials in patients with Kaposi"s sarcoma determined that the overall cost to achieve objective response was substantially lower with pegylated liposomal doxorubicin (Doxil/Caelyx [PLD]) than with liposomal daunorubicin (DaunoXome [DNX]). Doxorubicin glycosylphosphatidylinositol specific phospholipase D1 Homo sapiens